Side-by-side comparison of AI visibility scores, market position, and capabilities
Olathe KS GPS and wearables (NASDAQ: GRMN) $6.3B FY2024 revenue (+18%); auto OEM +69% BMW ramp, fitness +27%, FAA-certified aviation avionics competing with Apple Watch and Honeywell.
Garmin Ltd. is a Olathe, Kansas-based GPS navigation and wearable technology company — publicly traded on the NASDAQ (NASDAQ: GRMN) as an S&P 500 Consumer Discretionary component, incorporated in Switzerland — designing and manufacturing GPS devices, aviation instruments, marine electronics, automotive navigation, fitness wearables, and outdoor adventure devices through approximately 21,000 employees worldwide. In fiscal year 2024, Garmin reported revenues of $6.3 billion (+18% year-over-year), with its Auto OEM segment growing 69% following the production ramp of BMW vehicle infotainment systems, and Fitness segment growing 27% on continued strength of the Forerunner, Venu, and Lily wearable lines. Garmin's diversified five-segment model (Auto, Aviation, Marine, Outdoor, Fitness) provides recession resilience — when leisure marine spending declines, aviation and fitness growth compensate — with each segment generating both hardware and recurring software/service revenue from Connect IQ app downloads, Garmin Connect subscriptions, and aviation database subscription services. CEO Cliff Pemble leads Garmin's strategy of hardware excellence in GPS-intensive applications where Apple and Samsung cannot effectively compete: Garmin's aviation GPS units (GNS, GTN, G3X avionics) are FAA-certified instruments embedded in hundreds of thousands of light aircraft cockpits, requiring Garmin-specific recertification to replace.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.